These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25191940)

  • 1. Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1δ and ε with nanomolar inhibitory activity on cancer cell proliferation.
    Richter J; Bischof J; Zaja M; Kohlhof H; Othersen O; Vitt D; Alscher V; Pospiech I; García-Reyes B; Berg S; Leban J; Knippschild U
    J Med Chem; 2014 Oct; 57(19):7933-46. PubMed ID: 25191940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε.
    Bischof J; Leban J; Zaja M; Grothey A; Radunsky B; Othersen O; Strobl S; Vitt D; Knippschild U
    Amino Acids; 2012 Oct; 43(4):1577-91. PubMed ID: 22331384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
    García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
    J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
    Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.
    Yuan F; Li D; Guo M; Fang T; Sun J; Qi F; Rao Q; Zhao Z; Huang P; Yang B; Xia J
    Biochem Biophys Res Commun; 2020 Mar; 523(3):809-815. PubMed ID: 31954519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
    Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
    Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
    Cheong JK; Nguyen TH; Wang H; Tan P; Voorhoeve PM; Lee SH; Virshup DM
    Oncogene; 2011 Jun; 30(22):2558-69. PubMed ID: 21258417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(1H-Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1δ/ε inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Karthikeyan C; Jharia P; Waiker DK; Nusbaum AC; Amawi H; Kirwen EM; Christman R; Arudra SKC; Meijer L; Tiwari AK; Trivedi P
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2663-2667. PubMed ID: 28487075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.
    Monastyrskyi A; Nilchan N; Quereda V; Noguchi Y; Ruiz C; Grant W; Cameron M; Duckett D; Roush W
    Bioorg Med Chem; 2018 Feb; 26(3):590-602. PubMed ID: 29289448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor.
    Long A; Zhao H; Huang X
    J Med Chem; 2012 Jan; 55(2):956-60. PubMed ID: 22168824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.
    Janovska P; Verner J; Kohoutek J; Bryjova L; Gregorova M; Dzimkova M; Skabrahova H; Radaszkiewicz T; Ovesna P; Vondalova Blanarova O; Nemcova T; Hoferova Z; Vasickova K; Smyckova L; Egle A; Pavlova S; Poppova L; Plevova K; Pospisilova S; Bryja V
    Blood; 2018 Mar; 131(11):1206-1218. PubMed ID: 29317454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
    Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer.
    Liu M; Hu Y; Lu S; Lu M; Li J; Chang H; Jia H; Zhou M; Ren F; Zhong J
    Int J Biol Sci; 2020; 16(5):882-892. PubMed ID: 32071557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.
    Peifer C; Abadleh M; Bischof J; Hauser D; Schattel V; Hirner H; Knippschild U; Laufer S
    J Med Chem; 2009 Dec; 52(23):7618-30. PubMed ID: 19591487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε.
    de Souza Gama FH; Dutra LA; Hawgood M; Dos Reis CV; Serafim RAM; Ferreira MA; Teodoro BVM; Takarada JE; Santiago AS; Balourdas DI; Nilsson AS; Urien B; Almeida VM; Gileadi C; Ramos PZ; Salmazo A; Vasconcelos SNS; Cunha MR; Mueller S; Knapp S; Massirer KB; Elkins JM; Gileadi O; Mascarello A; Lemmens BBLG; Guimarães CRW; Azevedo H; Couñago RM
    J Med Chem; 2024 Jun; 67(11):8609-8629. PubMed ID: 38780468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.
    Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B
    Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the potent and selective inhibition of casein kinase 1 epsilon.
    Long AM; Zhao H; Huang X
    J Med Chem; 2012 Nov; 55(22):10307-11. PubMed ID: 23106386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties.
    Bibian M; Rahaim RJ; Choi JY; Noguchi Y; Schürer S; Chen W; Nakanishi S; Licht K; Rosenberg LH; Li L; Feng Y; Cameron MD; Duckett DR; Cleveland JL; Roush WR
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4374-80. PubMed ID: 23787102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 2,5-diaminobenzamide derivatives as anti-proliferating agents.
    Lee SH; Park JW; Hong JE; Park JW; Lee J
    Arch Pharm Res; 2009 Jun; 32(6):803-12. PubMed ID: 19557356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.
    Ianes C; Xu P; Werz N; Meng Z; Henne-Bruns D; Bischof J; Knippschild U
    Amino Acids; 2016 Feb; 48(2):579-92. PubMed ID: 26464264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.